Here are the latest stock price details of India's top MNC Pharma stocks. For more detailed updates, read our MNC Pharma sector report and check the latest MNC Pharma sector results.
Free Guide: Find the Next Crorepati Stock in this Futuristic Industry
SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
---|---|---|---|---|
ABBOTT INDIA | 12,973.85 1.19% | 12,982.15 1.38% | More Info ![]() |
|
GSK PHARMA | 1,672.55 1.63% | 1,674.60 1.78% | More Info ![]() |
|
NIFTY 50 | Not Listed | 12,086.70 0.96% | More Info ![]() |
|
NOVARTIS | 689.90 -0.07% | Not Listed | More Info ![]() |
|
PFIZER | 4,333.10 1.20% | 4,340.70 0.67% | More Info ![]() |
|
PROCTER & GAMBLE HEALTH | 4,136.95 0.10% | 4,136.00 -0.06% | More Info ![]() |
|
S&P BSE SENSEX | 41,009.71 1.05% | Not Listed | More Info ![]() |
|
SANOFI INDIA | 6,974.00 0.92% | 6,964.15 0.64% | More Info ![]() |
BSE prices: December 13, 2019 (Close) NSE prices: December 13, 2019 (Close)
The NIFTY PHARMA Index was at 8,030.1 (down 0.2%). The index is down 22.1% over the last 30 days. And over the last 1 year, it has lost 14.5%.
Within the MNC Pharma sector, the top gainers were GSK PHARMA (up 1.6%) and PFIZER (up 1.2%). On the other hand, NOVARTIS (down 0.1%) was the top loser.
Meanwhile, the benchmark NIFTY 50 was at 12,086.7 (up 1.0%).
| |
Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.
For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.
Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.
Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.
Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsWhat to do after every trade.
What we can learn from one of the greatest traders to have ever lived.
This corner of the market could provide more returns than blue chips in 2020.
Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.
2019 will be remembered as the year of great money-making IPOs...
More